Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Pulmonary Outcomes in People with Cystic Fibrosis who Stop Chronic Daily Therapies: The HERO-2 Study.
Journal: Annals of the American Thoracic Society
Published: January 21, 2026
Baseline Characteristics and Self-Reported Use of Chronic Daily Therapies of the Home Reported Outcomes With CFTR Modulator Therapy (HERO-2) Cohort.
Journal: Pediatric pulmonology
Published: January 16, 2025
Using Real-World Research to Study the Impact of Chronic Daily Therapy Discontinuation in Cystic Fibrosis: The Home-Reported Outcomes in Cystic Fibrosis 2 Study Design.
Journal: CHEST pulmonary
Published: June 29, 2024
Transgenic ferret models define pulmonary ionocyte diversity and function.
Journal: Nature
Published: November 19, 2022
Ferret models of alpha-1 antitrypsin deficiency develop lung and liver disease.
Journal: JCI insight
Published: August 07, 2020
In utero and postnatal VX-770 administration rescues multiorgan disease in a ferret model of cystic fibrosis.
Journal: Science translational medicine
Published: July 11, 2018
Infection Is Not Required for Mucoinflammatory Lung Disease in CFTR-Knockout Ferrets.
Journal: American journal of respiratory and critical care medicine
Published: January 13, 2018
Animal and model systems for studying cystic fibrosis.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: July 13, 2017
Principles of management of severe hyponatremia.
Journal: Journal of the American Heart Association
Published: March 26, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026